Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | pp60src- or c-Abl-mediated phosphorylation of nmMLCK at Y464 and Y471 increases MLC kinase activity | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
two major nmMLCK splice variants, nmMLCK1 (about 211 kDa) and nmMLCK2 (about 203 kDa), differ by 69 amino acids within exon 11 (partially deleted in nmMLCK2), a stretch that contains the highly phosphorylated Y464 and Y471. Recombinant expression of wild-type and mutant isozymes nmMLCK1 in Escherichia coli strain BL21(DE3), recombinant expression of Flag-tagged nmMLCK1, recombinant expression of two variants of the 1-494aa segments, wild type (P21-S147-V261)-1-494-biotin and a single SNP (P147)-1-494-biotin | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
P21H | site-directed mutagenesis, alters the N-terminal amino acid sequence of the non-muscle isoform of MLCK (nmMLCK) and is highly associated with susceptibility to acute lung injury and asthma, especially in individuals of African descent, the mutation causes minimal conformational changes compared to the wild-type enzyme | Homo sapiens |
S147P | site-directed mutagenesis, alters the N-terminal amino acid sequence of the non-muscle isoform of MLCK (nmMLCK) and is highly associated with susceptibility to acute lung injury and asthma, especially in individuals of African descent, the mutation causes minimal conformational changes compared to the wild-type enzyme | Homo sapiens |
V261A | site-directed mutagenesis, alters the N-terminal amino acid sequence of the non-muscle isoform of MLCK (nmMLCK) and is highly associated with susceptibility to acute lung injury and asthma, especially in individuals of African descent, the mutation causes minimal conformational changes compared to the wild-type enzyme | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | 14-3-3 binding of nmMLCK | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
phosphoprotein | reversible Ser/Thr and Tyr nmMLCK phosphorylation contributes to differential regulation of enzymatic activity and cellular spatial targeting of the kinase. cAMP-dependent protein kinase A (PKA)-mediated phosphorylation of nmMLCK exerts paradoxical effects on kinase activity depending on whether the Ser/Thr phosphorylation sites resides within the unique nmMLCK N-terminus, the putative Src homology (SH) 3-binding sequences, or the calcium/calmodulin binding region. Tyr phosphorylation of nmMLCK by pp60src or c-Abl occurs during barrier disruption, during recovery, as well as following exposure to barrier enhancing stimuli. pp60src- or c-Abl-mediated phosphorylation of nmMLCK at Y464 and Y471 increases MLC kinase activity. The two major nmMLCK splice variants, nmMLCK1 (about 211 kDa) and nmMLCK2 (about 203 kDa), differ by 69 amino acids within exon 11 (partially deleted in nmMLCK2), a stretch that contains the highly phosphorylated Y464 and Y471, suggesting that nmMLCK splice variants are differentially regulated by Tyr phosphorylation | Homo sapiens |
Purification (Comment) | Organism |
---|---|
recombinant wild-type and mutant isozymes nmMLCK1 from Escherichia coli strain BL21(DE3) by chromatography on a chitin column and dialysis | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
additional information | non-muscle isozyme | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | 14-3-3 binding of nmMLCK | Homo sapiens | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
More | structure-function analysis of the non-muscle myosin light chain kinase (nmMLCK) isoform by NMR spectroscopy and molecular modeling, overview | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
nmMLCK | - |
Homo sapiens |
non-muscle myosin light chain kinase | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | non-muscle myosin light chain kinase (nmMLCK) mutations P21H, S147P, and V261A (all located to loops that connect the immunoglobulin-like domains of nmMLCK) alter the enzyme conformation and the N-terminal amino acid sequence of the non-muscle isoform of MLCK and are highly associated with susceptibility to acute lung injury and asthma, especially in individuals of African descent | Homo sapiens |
additional information | structure-function analysis of the non-muscle myosin light chain kinase (nmMLCK) isoform by NMR spectroscopy and molecular modeling, overview. The two major nmMLCK splice variants, nmMLCK1 (about 211 kDa) and nmMLCK2 (about 203 kDa), differ by 69 amino acids within exon 11 (partially deleted in nmMLCK2), a stretch that contains the highly phosphorylated Y464 and Y471, suggesting that nmMLCK splice variants are differentially regulated by Tyr phosphorylation. Potential involvement of S147P and P21H SNP sites in nmMLCK1 in phosphorylation-dependent binding of 14-3-3 proteins | Homo sapiens |
physiological function | the MYLK gene encodes the multifunctional enzyme, myosin light chain kinase (MLCK), involved in isoform-specific non-muscle and smooth muscle contraction and regulation of vascular permeability during inflammation. Reversible Ser/Thr and Tyr nmMLCK phosphorylation contributes to differential regulation of enzymatic activity and cellular spatial targeting of the kinase. Inhibition of Tyr phosphatase activities results in significant accumulation of pTyr-containing nmMLCK, increased MLC kinase activity, endothelial cell contraction and barrier dysfunction. nmMLCK regulation by reversible Tyr phosphorylation, overview. The N-terminal SH2 and SH3 domain-binding motifs (including an SH2-binding motif containing phosphorylated Y464) regulate nmMLCK interactions with other cytoskeletal regulatory proteins | Homo sapiens |